ICON (ICLR) Tmuɣli n wazal
Ṛṛbem n lḥedd$172.48Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel-0.82%
Asnulfu n AI: ICLR
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
ICON PLC provides contract clinical research services to the global pharmaceutical industry. The company manages clinical trials in addition to offering data management, regulatory, and central laboratory services. ICON currently has offices in many countries.
